Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how Actinogen Medical Limited turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $5.49M | $9.93M | $4.89M | $3.64M | $1.98M | $3.52M | $4.86M | $3.30M | $1.42M | $3.95M |
| Revenue Growth? | -44.7% | +103.2% | +34.3% | +83.5% | -43.6% | -27.7% | +47.3% | +133.2% | -64.2% | 0.0% |
| Cost of Revenue? | $0 | $0 | $405,608 | $400,669 | $386,695 | $412,933 | $353,500 | $356,040 | $360,618 | $365,326 |
| Gross Profit? | $5.49M | $9.93M | $4.48M | $3.24M | $1.60M | $3.10M | $4.51M | $2.94M | $1.05M | $3.59M |
| Gross Margin? | +100.0% | +100.0% | +91.7% | +89.0% | +80.5% | +88.3% | +92.7% | +89.2% | +74.5% | +90.8% |
| Operating Expenses? | $20.42M | $22.77M | $15.47M | $12.77M | $5.52M | $8.50M | $14.95M | $9.21M | $4.24M | $7.21M |
| Operating Income? | -$14.93M | -$12.84M | -$10.58M | -$9.13M | -$3.53M | -$8.91M | -$9.61M | -$9.56M | -$4.60M | -$7.58M |
| EBITDA? | -$15.01M | -$12.92M | -$15.22M | -$12.72M | -$5.35M | -$8.20M | -$9.25M | -$5.91M | -$2.82M | -$3.26M |
| Income Before Tax | -$14.73M | -$22.98M | -$10.75M | -$9.50M | -$3.92M | -$8.65M | -$9.89M | -$9.39M | -$4.45M | -$7.38M |
| Income Tax Expense | $0 | -$9.93M | $0 | $0 | $0 | -$3.32M | $181,640 | -$3.16M | -$1.26M | -$3.75M |
| Net Income? | -$14.73M | -$13.04M | -$10.75M | -$9.50M | -$3.92M | -$5.33M | -$9.89M | -$6.23M | -$3.19M | -$3.63M |
| EPS? | $-0.00 | $-0.01 | $-0.01 | $-0.01 | $-0.00 | $-0.00 | $-0.01 | $-0.01 | $-0.00 | $-0.01 |
| Diluted EPS? | $-0.00 | $-0.01 | $-0.01 | $-0.01 | $-0.00 | $-0.00 | $-0.01 | $-0.01 | $-0.00 | $-0.01 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality